Hypoxic preconditioning induces the expression of prosurvival and proangiogenic markers in mesenchymal stem cells.
暂无分享,去创建一个
Periannan Kuppusamy | Shabnam Ahmed | P. Kuppusamy | K. Selvendiran | S. Chacko | Shabnam Ahmed | M. Kuppusamy | Mahmood Khan | Mahmood Khan | Karuppaiyah Selvendiran | Simi M Chacko | M Lakshmi Kuppusamy | Simi M. Chacko
[1] P. Kuppusamy,et al. Oxygen and oxygenation in stem-cell therapy for myocardial infarction. , 2010, Life sciences.
[2] A. Curt,et al. Stem cells in the treatment of chronic spinal cord injury: evaluation of somatosensitive-evoked potentials in 39 patients , 2010, Spinal Cord.
[3] Xinbin Chen,et al. Examination of the expanding pathways for the regulation of p21 expression and activity. , 2010, Cellular signalling.
[4] Eric Farrell,et al. The role of hypoxia in bone marrow-derived mesenchymal stem cells: considerations for regenerative medicine approaches. , 2010, Tissue engineering. Part B, Reviews.
[5] Young-ho Kim. Mesenchymal stem cells cultured under hypoxia escape from senescence via down-regulation of p16 and extracellular signal regulated kinase , 2010 .
[6] D. Mozaffarian,et al. Defining and Setting National Goals for Cardiovascular Health Promotion and Disease Reduction: The American Heart Association's Strategic Impact Goal Through 2020 and Beyond , 2010, Circulation.
[7] Ingo Müller,et al. Low physiologic oxygen tensions reduce proliferation and differentiation of human multipotent mesenchymal stromal cells , 2010, BMC Cell Biology.
[8] D. Meldrum,et al. PRECONDITIONING MESENCHYMAL STEM CELLS WITH TRANSFORMING GROWTH FACTOR-ALPHA IMPROVES MESENCHYMAL STEM CELL-MEDIATED CARDIOPROTECTION , 2010, Shock.
[9] J. Minguell,et al. Bone marrow-derived stem/progenitor cells: their use in clinical studies for the treatment of myocardial infarction. , 2009, Heart, lung & circulation.
[10] P. Kuppusamy,et al. Myocardial oxygenation and functional recovery in infarct rat hearts transplanted with mesenchymal stem cells. , 2009, American journal of physiology. Heart and circulatory physiology.
[11] Jun Jiang,et al. Anoxic preconditioning: a way to enhance the cardioprotection of mesenchymal stem cells. , 2009, International journal of cardiology.
[12] B. Dawn,et al. Bone marrow-derived mesenchymal stems cells and cardiac repair. , 2009, Minerva cardioangiologica.
[13] Meijing Wang,et al. Estradiol-treated mesenchymal stem cells improve myocardial recovery after ischemia. , 2009, Journal of Surgical Research.
[14] W. Teixeira,et al. Stem cells in the treatment of chronic spinal cord injury: evaluation of somatosensitive evoked potentials in 39 patients , 2009, Spinal Cord.
[15] W. Grossman,et al. VEGF improves survival of mesenchymal stem cells in infarcted hearts. , 2008, Biochemical and biophysical research communications.
[16] Ling Wei,et al. Transplantation of hypoxia-preconditioned mesenchymal stem cells improves infarcted heart function via enhanced survival of implanted cells and angiogenesis. , 2008, The Journal of thoracic and cardiovascular surgery.
[17] A. Ragnarsson,et al. Anterior myocardial infarction with acute percutaneous coronary intervention and intracoronary injection of autologous mononuclear bone marrow cells: safety, clinical outcome, and serial changes in left ventricular function during 12-months' follow-up. , 2008, Journal of the American College of Cardiology.
[18] Yuri Kim,et al. Oxygen and Cell Fate Decisions , 2008, Gene regulation and systems biology.
[19] J. Zweier,et al. Skeletal myoblasts transplanted in the ischemic myocardium enhance in situ oxygenation and recovery of contractile function. , 2007, American journal of physiology. Heart and circulatory physiology.
[20] Feng Zhao,et al. Hypoxia enhances proliferation and tissue formation of human mesenchymal stem cells. , 2007, Biochemical and biophysical research communications.
[21] Darwin J. Prockop,et al. Short-Term Exposure of Multipotent Stromal Cells to Low Oxygen Increases Their Expression of CX3CR1 and CXCR4 and Their Engraftment In Vivo , 2007, PloS one.
[22] K. Rudolph,et al. A Dual Role of p21 in Stem Cell Aging , 2007, Annals of the New York Academy of Sciences.
[23] G. Gerstenblith,et al. Preconditioning stem cells for cardiovascular disease: an important step forward. , 2007, Circulation Research.
[24] R. Zhao,et al. Proliferation and differentiation of bone marrow stromal cells under hypoxic conditions. , 2006, Biochemical and biophysical research communications.
[25] M. Ratajczak,et al. Migration of Bone Marrow and Cord Blood Mesenchymal Stem Cells In Vitro Is Regulated by Stromal‐Derived Factor‐1‐CXCR4 and Hepatocyte Growth Factor‐c‐met Axes and Involves Matrix Metalloproteinases , 2006, Stem cells.
[26] J. Ingwall,et al. Evidence supporting paracrine hypothesis for Akt‐modified mesenchymal stem cell‐mediated cardiac protection and functional improvement , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[27] P. Poole‐Wilson,et al. The dying stem cell hypothesis: immune modulation as a novel mechanism for progenitor cell therapy in cardiac muscle. , 2005, Journal of the American College of Cardiology.
[28] M. Csete,et al. Oxygen in the Cultivation of Stem Cells , 2005, Annals of the New York Academy of Sciences.
[29] M. Teh,et al. Ex vivo differentiation of human adult bone marrow stem cells into cardiomyocyte-like cells. , 2004, Biochemical and biophysical research communications.
[30] Gerhard Ehninger,et al. Mesenchymal Stem Cells Can Be Differentiated Into Endothelial Cells In Vitro , 2004, Stem cells.
[31] B. Fleischmann,et al. Bone marrow–derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation , 2004, Nature Medicine.
[32] P. Poole‐Wilson,et al. Regenerative capacity of the myocardium: implications for treatment of heart failure , 2004, The Lancet.
[33] Y. Geng. Molecular Mechanisms for Cardiovascular Stem Cell Apoptosis and Growth in the Hearts with Atherosclerotic Coronary Disease and Ischemic Heart Failure , 2003, Annals of the New York Academy of Sciences.
[34] N. Ferrara,et al. The biology of VEGF and its receptors , 2003, Nature Medicine.
[35] K Walsh,et al. Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. , 2001, Journal of molecular and cellular cardiology.
[36] S. R. Datta,et al. Cellular survival: a play in three Akts. , 1999, Genes & development.
[37] G. Sirugo,et al. Induction of Apoptosis and Inhibition of Cell Proliferation bysurvivin Gene Targeting* , 1998, The Journal of Biological Chemistry.
[38] M. Olivotto,et al. The role of hypoxia in the maintenance of hematopoietic stem cells. , 1993, Blood.
[39] Lisa J. Harris,et al. The role of hypoxia in stem cell differentiation and therapeutics. , 2011, The Journal of surgical research.
[40] S. Cheong,et al. Cryopreserved mesenchymal stromal cell treatment is safe and feasible for severe dilated ischemic cardiomyopathy. , 2010, Cytotherapy.
[41] C. Taylor. Mitochondria and cellular oxygen sensing in the HIF pathway. , 2008, The Biochemical journal.
[42] Jun Jiang,et al. Hypoxic preconditioning attenuates hypoxia/reoxygenation-induced apoptosis in mesenchymal stem cells , 2008, Acta Pharmacologica Sinica.
[43] J. Kastrup,et al. The influence of freezing and storage on the characteristics and functions of human mesenchymal stromal cells isolated for clinical use. , 2007, Cytotherapy.
[44] Paul D. Kessler,et al. Human Mesenchymal Stem Cells Differentiate to a Cardiomyocyte Phenotype in the Adult Murine Heart , 2002, Circulation.